Horizon is a global biopharmaceutical company focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Our portfolio, along with our pipeline, is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We are relentless in pursuing breakthroughs that boldly change the lives of the communities we serve. Discover more about our medicines in rheumatology, including the first and only biologic treatment for uncontrolled gout, and research for new therapeutic targets in gout and systemic sclerosis at www.HorizonTherapeutics.com.
LG Chem Life Sciences is a business division within LG Chem, engaged in the development, manufacturing, as well as commercializing pharmaceutical products globally. LG Chem Life Sciences seeks to expand and make a global presence by focusing on key core therapeutic areas of Immunology, Oncology, and Metabolic Diseases (specifically, diabetes and related metabolic diseases). To achieve such, its strategy is to actively pursue asset-centric global collaborations including strategic investments.
We are dedicated to pioneering ways to leverage the power of oral enzymes with our novel biologic platform to treat metabolic disorders and beyond. As a mission-driven organization, we are committed to developing novel treatments for people who have—until now—endured without any therapeutic options.
Our first-of-its-kind oral enzyme platform has the power to treat patients with severe and underserved metabolic disorders by breaking down harmful substances in the gastrointestinal (GI) tract, such as oxalate and urate. With our targeted approach, our therapeutics have the potential to reduce the elevated levels of harmful metabolites before they result in severe, debilitating consequences including kidney stones, gout, chronic kidney disease, and end-stage kidney disease.
As an agile and solutions-oriented organization, every decision we make is driven by data and consensus. Improving the lives of patients is the motivation for what we do; passion for innovation drives how we do it.
